Inhibition of HMG-CoA reductase activity by hypercholesterolaemia reduces leukocyte recruitment and MCP-1 production

被引:10
|
作者
Fruscella, P [1 ]
Romano, M [1 ]
Albani, D [1 ]
Bernasconi, S [1 ]
Luini, W [1 ]
Bruno, A [1 ]
Salmona, M [1 ]
Diomede, L [1 ]
机构
[1] Mario Negri Inst Pharmacol Res, Dept Mol Pharmacol & Biochem, I-20157 Milan, Italy
关键词
chemokines; cholesterol; HMG-CoA reductase; MCP-1; rodent;
D O I
10.1006/cyto.1999.0602
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
To clarify the relationship between cholesterol homeostasis and inflammation we studied the effect of hypercholesterolaemia on in vivo cytokine production and leukocyte migration, in a murine model of local inflammation. Hypercholesterolaemia reduced of 40% the leukocyte recuitment by inhibiting interleukin-6 and monocyte chemotactic protein-1 production in the pouch exudate, without affecting vascular permeability or leukocytes motility. (C) 2000 Academic Press.
引用
收藏
页码:1100 / 1103
页数:4
相关论文
共 50 条
  • [21] Synthesis and HMG-CoA reductase inhibition of 2-cyclopropyl-4-thiophenyl-quinoline mevalonolactones
    Zhao, Shikui
    Zhou, Weicheng
    Liu, Jun
    BIOORGANIC & MEDICINAL CHEMISTRY, 2009, 17 (23) : 7915 - 7923
  • [22] Inhibition of HMG-CoA reductase activity and cholesterol permeation through Caco-2 cells by caffeoylquinic acids from Vernonia condensata leaves
    Arantes, Ana A.
    Fale, Pedro L.
    Costa, Larissa C. B.
    Pacheco, Rita
    Ascensao, Lia
    Serralheiro, Maria Luisa
    REVISTA BRASILEIRA DE FARMACOGNOSIA-BRAZILIAN JOURNAL OF PHARMACOGNOSY, 2016, 26 (06): : 738 - 743
  • [23] Inhibition of HMG-CoA reductase activity and cholesterol permeation through Caco-2 cells by caffeoylquinic acids from Vernonia condensata leaves
    Ana A. Arantes
    Pedro L. Falé
    Larissa C. B. Costa
    Rita Pacheco
    Lia Ascensão
    Maria Luísa Serralheiro
    Revista Brasileira de Farmacognosia, 2016, 26 : 738 - 743
  • [24] HMG CoA reductase inhibition reduces sarcolemmal Na+-K+ pump density
    Gray, DF
    Bundgaard, H
    Hansen, PS
    Buhagiar, KA
    Mihailidou, AS
    Jessup, W
    Kjeldsen, K
    Rasmussen, HH
    CARDIOVASCULAR RESEARCH, 2000, 47 (02) : 329 - 335
  • [25] Luciferase-based HMG-CoA reductase degradation assay for activity and selectivity profiling of oxy(lano)sterols
    Sagimori, Ikuya
    Yoshioka, Hiromasa
    Hashimoto, Yuichi
    Ohgane, Kenji
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (03)
  • [26] Optimization,validation and application of an assay for the activity of HMG-CoA reductase in vitro by LC–MS/MS
    Jing Wang
    Ji-Ye Sun
    Chun-Jie Sha
    Yu-Feng Shao
    Yan-Hong Liu
    You-Xin Li
    Zhen-Wen Duan
    Wan-Hui Liu
    Journal of Pharmaceutical Analysis, 2015, 5 (06) : 383 - 388
  • [27] Reduction of oxysterol levels up-regulates HMG-CoA reductase activity in rat liver
    Tamasawa, N
    Hayakari, M
    Murakami, H
    Matsui, J
    Suda, T
    ATHEROSCLEROSIS, 1997, 131 (02) : 237 - 242
  • [28] The diurnal variation of hepatic HMG-CoA reductase activity is due to changes in the level of immunoreactive protein
    Ness, GC
    Chambers, GM
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1996, 327 (01) : 41 - 44
  • [29] Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies
    Asma Ressaissi
    Nebil Attia
    Pedro Luis Falé
    Rita Pacheco
    Bruno L. Victor
    Miguel Machuqueiro
    Maria Luísa M. Serralheiro
    Archives of Pharmacal Research, 2017, 40 : 1278 - 1286
  • [30] Isorhamnetin derivatives and piscidic acid for hypercholesterolemia: cholesterol permeability, HMG-CoA reductase inhibition, and docking studies
    Ressaissi, Asma
    Attia, Nebil
    Fale, Pedro Luis
    Pacheco, Rita
    Victor, Bruno L.
    Machuqueiro, Miguel
    Serralheiro, Maria Luisa M.
    ARCHIVES OF PHARMACAL RESEARCH, 2017, 40 (11) : 1278 - 1286